Literature DB >> 15147349

Recognition of nonpeptide antigens by human V gamma 9V delta 2 T cells requires contact with cells of human origin.

A E Green1, A Lissina, S L Hutchinson, R E Hewitt, B Temple, D James, J M Boulter, D A Price, A K Sewell.   

Abstract

SUMMARY It is becoming apparent that gamma delta T cells form an important part of the adaptive immune response. However, the ligands recognized by gamma delta T cell receptors (TCRs) and the exact biological function of the cells that express this receptor remain unclear. Numerous studies have shown that the dominant human peripheral blood subset of gamma delta T cells, which express a V gamma 9V delta 2 TCR, can activate in response to low molecular weight nonpeptidic molecules. Some of these components have been purified from bacteria or parasites. We examined the activation of polyclonal gamma delta T cell lines, clones with V gamma 9V delta 2 and V gamma 9V delta 1 TCRs, and gamma delta T cells directly ex vivo in response to multiple phosphate, alkylamine and aminobisphosphonate (nBP) antigens and purified protein derivative from Mycobacterium tuberculosis (PPD). V gamma 9V delta 2 T cells were able to respond to multiple small organic molecules of highly variable structure whereas cells expressing a similar V gamma 9 chain paired with a V delta 1 chain failed to recognize these antigens. Thus, the TCR delta chain appears to make an important contribution to the recognition of these antigens. The kinetics of responses to alkylphosphate and alkylamine antigens differ from those of responses to the nBP pamidronate. These different classes of antigen are believed to have differed mechanisms of action. Such differences explain why nBPs can be pulsed onto antigen presenting cells (APCs) and still retain their ability to activate gamma delta T cells while alkylphosphate and alkylamine antigens cannot. We also demonstrate that a substantial proportion of the cells that produce IFN gamma directly ex vivo in response to PPD are gamma delta T cells and that gamma delta T cell activation requires contact with cells of human origin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147349      PMCID: PMC1809052          DOI: 10.1111/j.1365-2249.2004.02472.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  62 in total

1.  Quantitative structure--activity relations for gammadelta T cell activation by phosphoantigens.

Authors:  William Gossman; Eric Oldfield
Journal:  J Med Chem       Date:  2002-10-24       Impact factor: 7.446

2.  Recognition mechanism of non-peptide antigens by human gammadelta T cells.

Authors:  Seiji Yamashita; Yoshimasa Tanaka; Masashi Harazaki; Bunzo Mikami; Nagahiro Minato
Journal:  Int Immunol       Date:  2003-11       Impact factor: 4.823

3.  The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities.

Authors:  Sarah L Hutchinson; Linda Wooldridge; Sabrina Tafuro; Bruno Laugel; Meir Glick; Jonathan M Boulter; Bent K Jakobsen; David A Price; Andrew K Sewell
Journal:  J Biol Chem       Date:  2003-04-15       Impact factor: 5.157

4.  Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate.

Authors:  Yu Kato; Yoshimasa Tanaka; Hidenori Tanaka; Seiji Yamashita; Nagahiro Minato
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

5.  Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands.

Authors:  F Lang; M A Peyrat; P Constant; F Davodeau; J David-Ameline; Y Poquet; H Vié; J J Fournié; M Bonneville
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

Review 6.  Antitumor effects of bisphosphonates.

Authors:  Jonathan R Green
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

7.  Gamma delta T cell receptor-bearing lymphocytes during Epstein-Barr virus infection.

Authors:  P De Paoli; D Gennari; P Martelli; V Cavarzerani; R Comoretto; G Santini
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

8.  A subset of gamma delta lymphocytes is increased during HIV-1 infection.

Authors:  P De Paoli; D Gennari; P Martelli; G Basaglia; M Crovatto; S Battistin; G Santini
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

9.  Resident pulmonary lymphocytes expressing the gamma/delta T-cell receptor.

Authors:  A Augustin; R T Kubo; G K Sim
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

10.  Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites.

Authors:  Francesco Dieli; Fabrizio Poccia; Martin Lipp; Guido Sireci; Nadia Caccamo; Caterina Di Sano; Alfredo Salerno
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  28 in total

Review 1.  Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.

Authors:  Eric Champagne; Laurent O Martinez; Pierre Vantourout; Xavier Collet; Ronald Barbaras
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Role of nutrients in the development of neonatal immune response.

Authors:  Susanna Cunningham-Rundles; Hong Lin; Deborah Ho-Lin; Ann Dnistrian; Barrie R Cassileth; Jeffrey M Perlman
Journal:  Nutr Rev       Date:  2009-11       Impact factor: 7.110

Review 3.  Defining the nature of human γδ T cells: a biographical sketch of the highly empathetic.

Authors:  Shirin Kalyan; Dieter Kabelitz
Journal:  Cell Mol Immunol       Date:  2012-10-22       Impact factor: 11.530

4.  Vgamma2Vdelta2 T Cell Receptor recognition of prenyl pyrophosphates is dependent on all CDRs.

Authors:  Hong Wang; Zhimei Fang; Craig T Morita
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

5.  Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor.

Authors:  Jonathan Fisher; Pierre Abramowski; Nisansala Dilrukshi Wisidagamage Don; Barry Flutter; Anna Capsomidis; Gordon Weng-Kit Cheung; Kenth Gustafsson; John Anderson
Journal:  Mol Ther       Date:  2017-03-22       Impact factor: 11.454

Review 6.  γδ T-APCs: a novel tool for immunotherapy?

Authors:  Bernhard Moser; Matthias Eberl
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

7.  Antigen-presenting effects of effector memory Vγ9Vδ2 T cells in rheumatoid arthritis.

Authors:  Chaoying Hu; Liu Qian; Yi Miao; Qiuyu Huang; Ping Miao; Ping Wang; Qiwen Yu; Hong Nie; Jiying Zhang; Dongyi He; Rong Xu; Xuehua Chen; Bingya Liu; Dongqing Zhang
Journal:  Cell Mol Immunol       Date:  2011-12-05       Impact factor: 11.530

Review 8.  Gammadelta T-cells: potential regulators of the post-burn inflammatory response.

Authors:  Martin G Schwacha
Journal:  Burns       Date:  2008-10-31       Impact factor: 2.744

9.  Acute effects of intravenous administration of pamidronate in patients with osteoporosis.

Authors:  Mie Jin Lim; Seong Ryul Kwon; Shin-Goo Park; Won Park
Journal:  J Korean Med Sci       Date:  2010-08-14       Impact factor: 2.153

10.  Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells.

Authors:  Stefano Vavassori; Anil Kumar; Gan Siok Wan; Gundimeda S Ramanjaneyulu; Marco Cavallari; Sary El Daker; Travis Beddoe; Alex Theodossis; Neal K Williams; Emma Gostick; David A Price; Dinish U Soudamini; Kong Kien Voon; Malini Olivo; Jamie Rossjohn; Lucia Mori; Gennaro De Libero
Journal:  Nat Immunol       Date:  2013-07-21       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.